logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Genor Biopharma-B (02595.HK) repurchased 135,000 shares for HK$3.8307 million on October 8.

date
08/10/2026
Zhitong Finance APP News, GenFleet Therapeutics-B (02595.HK) announced that on October 8, 2026, it spent HK$3.8307 million to repurchase 135,000 shares.
Latest
2 m ago
ICBC (601398.SH)'s application for issuing A-shares to specific targets has been accepted by the Shanghai Stock Exchange.
3 m ago
SF Intra-city (09699.HK) repurchased 81,000 shares for HK$695,100 on October 8.
4 m ago
Hong Kong Commerce and Economic Development Bureau: Deepen Hong Kong's economic and trade cooperation with the mainland and continue to expand the international network.
5 m ago
Jianyuan Institute (603183.SH): Hanqi Investment Plans to Make a Tender Offer for 9.9% of the Company's Shares; Stock Resumes Trading
5 m ago
Sihuan Pharmaceutical (00460.HK) makes a strategic investment in Hanteng Biotech, enhancing its layout across the entire regenerative medical aesthetics industry chain.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.